APA

Harousseau J., Attal M., Avet-Loiseau H., Marit G., Caillot D., Mohty M., Lenain P., Hulin C., Facon T., Casassus P., Michallet M., Maisonneuve H., Benboubker L., Maloisel F., Petillon M., Webb I., Mathiot C. & Moreau P. (20101108). Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Harousseau Jean-Luc, Attal Michel, Avet-Loiseau Hervé, Marit Gerald, Caillot Denis, Mohty Mohamad, Lenain Pascal, Hulin Cyrille, Facon Thierry, Casassus Philippe, Michallet Mauricette, Maisonneuve Hervé, Benboubker Lotfi, Maloisel Frédéric, Petillon Marie-Odile, Webb Iain, Mathiot Claire and Moreau Philippe. 20101108. Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Harousseau J., Attal M., Avet-Loiseau H., Marit G., Caillot D., Mohty M., Lenain P., Hulin C., Facon T., Casassus P., Michallet M., Maisonneuve H., Benboubker L., Maloisel F., Petillon M., Webb I., Mathiot C. and Moreau P. (20101108). Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Harousseau Jean-Luc, Attal Michel, Avet-Loiseau Hervé, Marit Gerald, Caillot Denis, Mohty Mohamad, Lenain Pascal, Hulin Cyrille, Facon Thierry, Casassus Philippe, Michallet Mauricette, Maisonneuve Hervé, Benboubker Lotfi, Maloisel Frédéric, Petillon Marie-Odile, Webb Iain, Mathiot Claire and Moreau Philippe. Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20101108.